Alloantigen gene therapy for squamous cell carcinoma of the head and neck: results of a phase-1 trial. [electronic resource]
Producer: 19981028Description: 1097-104 p. digitalISSN:- 0886-4470
- Adult
- Aged
- Carcinoma, Squamous Cell -- immunology
- Combined Modality Therapy
- DNA
- DNA, Recombinant
- Female
- Genetic Therapy -- adverse effects
- HLA-B7 Antigen -- adverse effects
- Head and Neck Neoplasms -- immunology
- Histocompatibility Testing
- Humans
- Immunohistochemistry
- Lipids -- adverse effects
- Male
- Middle Aged
- Patient Selection
- Plasmids -- adverse effects
- Prospective Studies
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.